223 results
8-K
EX-99.1
CTLT
Catalent, Inc.
29 Aug 24
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
7:47am
, purchased components and raw materials; changes in market access or healthcare reimbursement in the United States or internationally; fluctuations
8-K
EX-99.1
CTLT
Catalent, Inc.
8 May 24
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
4:20pm
investment firm focused on life sciences. Under private ownership, we will benefit from access to additional capital and resources to provide enhanced … , including active pharmaceutical ingredients, excipients, purchased components and raw materials; changes in market access or healthcare reimbursement
DEFM14A
jq2u3q1t qf
15 Apr 24
Proxy related to merger
7:35am
PREM14A
xsgon7
3 Apr 24
Preliminary proxy related to merger
4:31pm
8-K
EX-99.1
qdr4ug
9 Feb 24
Catalent, Inc. Reports Second Quarter Fiscal 2024 Results
8:04am
DEFA14A
tl3y89
5 Feb 24
Additional proxy soliciting materials
5:22pm
DEFA14A
3rzp 7bbwuy0aisl
5 Feb 24
Additional proxy soliciting materials
7:03am
8-K
EX-2.1
fwghu7
5 Feb 24
Novo Holdings to Acquire Catalent
7:00am
8-K
EX-10.1
61u1av
19 Dec 23
Catalent Announces Closing of Incremental Term Loans
4:22pm
8-K/A
EX-99.2
7500fn
8 Dec 23
Revised Financial Highlights
5:07pm
8-K/A
EX-99.1
njz2x 8n4pg6cipvq
8 Dec 23
Revised Financial Highlights
5:07pm